X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58) 58
hematology (54) 54
female (51) 51
male (51) 51
index medicus (50) 50
adult (47) 47
middle aged (46) 46
retrospective studies (33) 33
transplantation (33) 33
aged (32) 32
treatment outcome (30) 30
stem cells (25) 25
survival (24) 24
transplantation, homologous (24) 24
adolescent (23) 23
hematopoietic stem cell transplantation (20) 20
recurrence (20) 20
hematopoietic stem cell transplantation - methods (19) 19
disease-free survival (18) 18
hematopoietic stem cells (18) 18
immunology (18) 18
survival analysis (18) 18
young adult (18) 18
child (16) 16
leukemia (16) 16
allogeneic stem cell transplantation (15) 15
hematopoietic stem cell transplantation - mortality (15) 15
oncology (15) 15
risk factors (15) 15
therapy (15) 15
bone marrow (14) 14
bone-marrow-transplantation (14) 14
child, preschool (14) 14
myelodysplastic syndromes - therapy (14) 14
prognosis (14) 14
myelodysplastic syndromes (13) 13
survival rate (13) 13
hematology, oncology and palliative medicine (12) 12
medical research (12) 12
medicine, experimental (12) 12
myelodysplastic syndromes - mortality (12) 12
blood (11) 11
follow-up studies (11) 11
stem cell transplantation (11) 11
stem-cell transplantation (11) 11
transplantation, autologous (11) 11
acute myeloid-leukemia (10) 10
europe (10) 10
hematopoietic stem cell transplantation - adverse effects (10) 10
mortality (10) 10
patient outcomes (10) 10
analysis (9) 9
classification (9) 9
infant (9) 9
multivariate analysis (9) 9
myelodysplastic syndrome (9) 9
siblings (9) 9
transplantation conditioning (9) 9
transplantation conditioning - methods (9) 9
unrelated donors (9) 9
follow-up (8) 8
mds (8) 8
patients (8) 8
age factors (7) 7
cancer (7) 7
care and treatment (7) 7
chemotherapy (7) 7
chronic myelogenous leukemia (7) 7
graft vs host disease - etiology (7) 7
leukemia, myeloid, acute - therapy (7) 7
versus-host-disease (7) 7
acute myelogenous leukemia (6) 6
allografts (6) 6
bone-marrow (6) 6
europe - epidemiology (6) 6
graft vs host disease - mortality (6) 6
ibrutinib (6) 6
multiple myeloma - therapy (6) 6
prognostic scoring system (6) 6
registries (6) 6
relapse (6) 6
time factors (6) 6
usage (6) 6
acute disease (5) 5
aml (5) 5
articles (5) 5
diagnosis (5) 5
ebmt (5) 5
graft vs host disease - prevention & control (5) 5
health aspects (5) 5
impact (5) 5
leukemia, lymphocytic, chronic, b-cell - mortality (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - therapy (5) 5
leukemia, myeloid, acute - mortality (5) 5
life sciences (5) 5
lymphocyte transfusion (5) 5
marrow-transplantation (5) 5
multiple myeloma - mortality (5) 5
original (5) 5
outcomes (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 2017, Volume 178, Issue 4, pp. 521 - 533
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2018, Volume 183, Issue 1, pp. 110 - 118
Journal Article
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 2017, Volume 177, Issue 5, pp. 759 - 765
Journal Article
Transfusion, ISSN 0041-1132, 2014, Volume 54, Issue 10, pp. 2514 - 2522
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2015, Volume 171, Issue 4, pp. 585 - 594
Summary We explored the feasibility of unrelated donor haematopoietic stem cell transplant (HSCT) upfront without prior immunosuppressive therapy (IST) in... 
paediatric aplastic anaemia | transplantation | aplastic anaemia | Transplantation | Aplastic anaemia | Paediatric aplastic anaemia | MULTICENTER | CYCLOPHOSPHAMIDE | BONE-MARROW-TRANSPLANTATION | DONOR TRANSPLANTS | FOLLOW-UP | CHRONIC GRAFT | CHILDREN | IMMUNOSUPPRESSIVE THERAPY | RABBIT ANTITHYMOCYTE GLOBULIN | HEMATOLOGY | CYCLOSPORINE | Adenoviridae Infections - drug therapy | Graft vs Host Disease - epidemiology | Peripheral Blood Stem Cell Transplantation - adverse effects | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Infant | Male | Living Donors | Anemia, Aplastic - therapy | Case-Control Studies | Bone Marrow Transplantation - statistics & numerical data | Primary Graft Dysfunction - epidemiology | Young Adult | Adenoviridae Infections - epidemiology | Anemia, Aplastic - mortality | Blood Transfusion - utilization | Adult | Female | Retrospective Studies | Postoperative Complications - drug therapy | Child | Virus Activation | Length of Stay - statistics & numerical data | Siblings | T-Lymphocytes | Kaplan-Meier Estimate | Survival Rate | Treatment Outcome | Postoperative Complications - epidemiology | Herpesviridae Infections - drug therapy | Peripheral Blood Stem Cell Transplantation - statistics & numerical data | Cyclosporine - therapeutic use | Disease-Free Survival | Graft vs Host Disease - drug therapy | Adolescent | Bone Marrow Transplantation - adverse effects | Quality of Life | Graft vs Host Disease - prevention & control | Antilymphocyte Serum | Histocompatibility | Herpesviridae Infections - epidemiology | Pediatrics | Medical research | Immunotherapy | Stem cells | Aplastic anemia | Medicine, Experimental | Hematopoietic stem cells
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 10/2017, Volume 17, Issue 10, pp. 667 - 675.e2
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 9/2013, Volume 57, Issue 6, pp. 794 - 802
Background. The objective of this analysis was to investigate prognostic factors that influence the outcome of Epstein-Barr virus (EBV)—related posttransplant... 
Health outcomes | Immunosuppression | Lymphoproliferative disorders | Mortality | Predisposing factors | Viral diseases | Transplantation | Graft vs host disease | Epstein Barr virus infections | ARTICLES AND COMMENTARIES | Blood | hematopoietic stem cell transplantation | risk factors | Epstein-Barr virus | post-transplant lymphoproliferative disorder | prognostic model | INFECTIOUS DISEASES | MANAGEMENT | PROGNOSTIC-FACTORS | LOAD | SCT | MICROBIOLOGY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | REACTIVATION | LYMPHOMA | PTLD | LYMPHOCYTES | Prognosis | Humans | Middle Aged | Child, Preschool | Infant | Epstein-Barr Virus Infections - surgery | Viral Load | Herpesvirus 4, Human - isolation & purification | Adult | Retrospective Studies | Child | Epstein-Barr Virus Infections - epidemiology | Lymphoproliferative Disorders - surgery | Epstein-Barr Virus Infections - virology | Lymphoproliferative Disorders - virology | Risk Factors | Kaplan-Meier Estimate | Europe - epidemiology | Hematopoietic Stem Cell Transplantation | Rituximab | Epstein-Barr Virus Infections - drug therapy | Lymphoproliferative Disorders - epidemiology | DNA, Viral - blood | Adolescent | Lymphoproliferative Disorders - drug therapy | Aged | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. 507 - 513
Journal Article
Journal Article